SLU-PP-332 60mg — Vial Spec, Reconstitution Math & COA
High-throughput laboratory research protocols evaluating Estrogen-Related Receptor (ERR) agonism often require concentrated bulk formats. A 60mg vial spec of SLU-PP-332 provides the required mass for multi-specimen rodent studies, automated assay plating, and extended in vitro testing regimes without frequent lot transitions.
Quick answer
High-throughput laboratory research protocols evaluating Estrogen-Related Receptor (ERR) agonism often require concentrated bulk formats. A 60mg vial spec of SLU-PP-332 provides the required mass for multi-specimen rodent studies, automated assay plating, and extended in vitro testing regimes without frequent lot transitions.
Key takeaways
- A 60mg vial of SLU-PP-332 represents a high-yield unit designed primarily for academic labs, Contract Research Organizations (CROs), and industrial screening facilities.
- SLU-PP-332 is a synthetic small-molecule agonist designed to selectively target Estrogen-Related Receptors, specifically acting as a pan-agonist across ERRα, ERRβ, and ERRγ isoforms.
- Accurate dilution of a 60mg lyophilized cake requires precise stoichiometric calculations based on the final target concentration required for working aliquots.
- Unlike standard hydrophilic peptides, SLU-PP-332 is a non-peptide synthetic small molecule exhibiting distinct hydrophobic properties.
Overview of SLU-PP-332 60mg Vial Specifications & Lab Availability
A 60mg vial of SLU-PP-332 represents a high-yield unit designed primarily for academic labs, Contract Research Organizations (CROs), and industrial screening facilities. In experimental setups requiring repeated dosing in rodent models or large-scale cell culture work, lower-yield vials necessitate frequent reconstitutions that introduce batch-to-batch variability. Utilizing a single 60mg mass standard standardizes stock solutions across longer experimental timelines.
While custom 60mg high-yield vials are produced for specialized high-throughput screening applications, investigators should review current catalog availability across our all peptides inventory. For standardized assays, researchers may also evaluate solid-state research formats such as SLU-PP-332 Capsules 250mcg depending on the delivery model specified in the protocol. PX1 Research delivers lyophilized research compounds with verified identity, precise fill weights, and consistent purity metrics.
Molecular Profile & ERR Receptor Agonism Mechanism
SLU-PP-332 is a synthetic small-molecule agonist designed to selectively target Estrogen-Related Receptors, specifically acting as a pan-agonist across ERRα, ERRβ, and ERRγ isoforms. In skeletal muscle tissue and cardiac myocytes, ERRs serve as key nuclear receptors that regulate nuclear-encoded mitochondrial gene expression. Preclinical studies suggest that activation of ERRα and ERRγ induces transcriptional cascades identical to those stimulated by physical endurance training.
In vitro data indicate that exposure to SLU-PP-332 upregulates genes associated with oxidative phosphorylation, fatty acid oxidation, and mitochondrial biogenesis, such as PGC-1α targets. In animal models, administration of ERR agonists has demonstrated an increase in oxidative muscle fiber type distribution, improved mitochondrial volume density, and enhanced maximal aerobic capacity without prior exercise conditioning. Consequently, the compound is widely studied within metabolic disease and exercise mimetic research frameworks.
Reconstitution Math & Concentration Matrix for 60mg Vials
Accurate dilution of a 60mg lyophilized cake requires precise stoichiometric calculations based on the final target concentration required for working aliquots. Because 60mg is a substantial mass, adding standard volume ranges (1mL to 3mL) yields significantly higher stock concentrations compared to standard 5mg or 10mg peptide vials. Researchers can utilize our automated reconstitution calculator to quickly verify custom volumetric math before solvent addition.
When adding 1.0 mL of compatible solvent to a 60mg vial, the resulting stock solution concentration is exactly 60.0 mg/mL (or 60 μg/μL). Adding 2.0 mL of solvent yields a concentration of 30.0 mg/mL (30 μg/μL), whereas 3.0 mL of diluent produces a 20.0 mg/mL (20 μg/μL) working solution. For micro-dosing in automated liquid handlers or microfluidic assays, intermediate secondary dilutions using laboratory-grade buffers are recommended to achieve nanogram- or micromolar-level working suspensions.
Laboratory Aliquoting & Solvent Compatibility Protocol
Unlike standard hydrophilic peptides, SLU-PP-332 is a non-peptide synthetic small molecule exhibiting distinct hydrophobic properties. Reconstitution in 100% aqueous solutions (such as plain sterile water or standard saline) may lead to incomplete solubilization or precipitation at higher concentrations like 60mg/mL. Primary stock solubilization typically requires organic solvents such as dimethyl sulfoxide (DMSO) or polyethylene glycol (PEG400).
For cell culture assays, a common protocol involves dissolving the 60mg mass in 100% research-grade DMSO to create a concentrated master stock (e.g., 60 mg/mL). This stock is then sub-aliquoted into single-use polypropylene microcentrifuge tubes to avoid repeated freeze-thaw cycles. Prior to application in culture media or animal models, stock aliquots are diluted into phosphate-buffered saline (PBS) or culture media, maintaining final DMSO concentrations below 0.1% v/v to eliminate solvent toxicity artifacts.
Quality Assurance: COA Issuance, HPLC/MS & Endotoxin Standards
High-mass vials such as the 60mg spec require strict quality control protocols to verify mass uniformity, chemical purity, and solvent clearance. Every production lot at PX1 Research undergoes rigorous testing in an ISO 17025 accredited laboratory prior to release. Final analytical reports are published directly to our open-access COA repository for verified research transparency.
Purity is quantitatively assessed via High-Performance Liquid Chromatography (HPLC), guaranteeing raw chemical purity exceeding 98.0%. Mass identity is confirmed through Mass Spectrometry (MS) to verify the exact molecular mass and structure of SLU-PP-332. Furthermore, because batch sizes of 60mg are frequently used in sensitive in vivo models, every lot undergoes chromogenic LAL endotoxin testing to confirm levels remain strictly under laboratory safety thresholds (<0.01 EU/μg).
Storage Stability & Thermal Degradation Parameters
In its original lyophilized form, a 60mg vial of SLU-PP-332 exhibits excellent long-term chemical stability. Unopened vials should be stored in a dark, temperature-controlled environment at -20°C for up to 24 months. For ultra-long-term archiving across multi-year research projects, storage at -80°C is recommended to completely arrest potential oxidative degradation.
Once reconstituted in DMSO or specialized co-solvent mixtures, liquid aliquots should be stored at -80°C to preserve chemical integrity. Solutions stored at 4°C are susceptible to precipitation out of solution over extended periods and should be brought to room temperature and gently vortexed prior to experimental use. Researchers tracking stability across variable storage regimes can access additional technical whitepapers in our centralized research library.
Comparative Analysis: SLU-PP-332 vs. Related Metabolic Compounds
Within metabolic and muscle performance research, SLU-PP-332 is evaluated alongside other small molecules and peptides targeting mitochondrial biogenesis and substrate utilization. A primary differentiator is receptor selectivity: while SLU-PP-332 acts specifically as an ERR pan-agonist, compounds like GW-501516 target Peroxisome Proliferator-Activated Receptor delta (PPARδ), activating distinct upstream lipid-oxidation pathways.
Similarly, SR-9009 functions as a Rev-ErbA agonist, modulating circadian clock genes alongside mitochondrial activity, whereas exercise-mimetic peptides like MotS-c act via mitochondrial-derived peptide pathways targeting AMPK activation. Researchers comparing these molecular targets frequently utilize multi-compound screening panels to map overlapping metabolic networks in skeletal muscle tissue.
Determining Optimal Vial Sizing for Experimental Design
Choosing between a high-yield 60mg vial spec and smaller single-trial formats depends on experimental scale and handling capabilities. Large-scale rodent studies involving high subject cohorts or high-frequency administration schedules benefit from the 60mg format due to volumetric consistency and reduced per-milligram processing costs. Facilities managing multi-investigator projects often establish centralized master stocks using bulk single-vial fills.
Conversely, pilot studies, initial dose-response assays, or facilities without ultra-low temperature storage infrastructure may prefer smaller unit sizes to minimize long-term solution storage risks. Institutional buyers requiring scaled quantities for facility-wide research programs can establish institutional supply agreements through our dedicated wholesale portal.
Handling Safety, Preclinical Safety Margin & Experimental Controls
SLU-PP-332 is strictly manufactured and distributed as a chemical reagent for laboratory research use only. It is not intended, designed, or approved for human consumption, clinical trials, or veterinary administration. Principal investigators must ensure that all laboratory personnel wear appropriate personal protective equipment (PPE), including nitrile gloves, lab coats, and safety eyewear, when handling raw powder or reconstituted solutions.
In preclinical animal models, researchers must establish clear control groups using solvent-matched vehicle solutions (e.g., identical DMSO/saline ratios without active compound) to account for potential carrier effects. All experimental waste must be disposed of according to institutional hazardous chemical handling standards and local regulatory requirements.
Frequently Asked Questions
What is the total mass and purity standard of a SLU-PP-332 60mg research vial?
A 60mg vial contains 60 milligrams of high-purity synthetic SLU-PP-332 powder. PX1 Research guarantees a minimum purity standard of ≥98% as verified by lot-matched HPLC and Mass Spectrometry analysis.
How do I calculate concentration when reconstituting a 60mg SLU-PP-332 vial?
Concentration is calculated by dividing total mass (60mg) by solvent volume added. For example, 1mL solvent yields 60mg/mL, 2mL yields 30mg/mL, and 3mL yields 20mg/mL. Researchers can use our online reconstitution calculator for instant precise math.
Which solvents are best suited for reconstituting high-mass SLU-PP-332 vials?
Because SLU-PP-332 is a hydrophobic small molecule, primary stock reconstitution is best achieved using organic solvents such as DMSO or PEG400. Once solubilized, secondary dilutions can be made in PBS or culture media for working assays.
Where can I verify the lot-specific Certificate of Analysis for my 60mg vial?
Lot-matched COAs displaying HPLC chromatograms, mass spec analysis, and endotoxin assay results are accessible via our public COA repository on the PX1 Research website.
What is the baseline mechanism of SLU-PP-332 in preclinical models?
SLU-PP-332 functions as a pan-agonist of Estrogen-Related Receptors (ERRα, ERRβ, ERRγ), promoting mitochondrial biogenesis, oxidative gene expression, and fatty acid oxidation in skeletal muscle and cardiac cells.
How should reconstituted SLU-PP-332 solutions be stored to prevent degradation?
Reconstituted stock aliquots in DMSO should be stored at -80°C for long-term stability. Avoid repeated freeze-thaw cycles by sub-aliquoting the master solution upon initial reconstitution.
Is SLU-PP-332 60mg approved for clinical or human administration?
No. SLU-PP-332 is an unapproved research compound manufactured strictly for in vitro laboratory and preclinical animal research. Human or veterinary administration is strictly prohibited.
What are the advantages of ordering 60mg vials versus smaller mass options for lab research?
High-mass 60mg vials reduce inter-batch variability across multi-animal or extended cell-culture protocols, streamline inventory management, and provide cost efficiency for high-throughput laboratory screening.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.